About The Report
The demand for coronary artery bypass graft procedures in South Korea is projected to reach USD 892.2 million by 2036, growing at a CAGR of 2.8% from USD 679.9 million in 2026. The quality of demand in this market is characterized by stability, driven by the ongoing prevalence of cardiovascular diseases and the established role of bypass surgeries in treatment protocols. Repeat usage is an important factor, as patients undergoing these procedures often require follow-up care or reintervention, contributing to steady demand over time. Buyer commitment levels are high, as hospitals and healthcare providers are likely to maintain long-term relationships with suppliers due to the critical and routine nature of these procedures. However, the pace of growth reflects the mature nature of this segment, with demand fluctuations more closely tied to healthcare policy changes, evolving treatment guidelines, and population health trends rather than speculative shifts in patient preferences.
The CABG market in South Korea is projected to experience steady growth from 2026 to 2036. Starting at USD 679.9 million in 2026, the industry is expected to rise to USD 698.6 million in 2027. By 2028, the industry value will reach USD 717.9 million, followed by USD 737.7 million in 2029. The industry will continue its growth, reaching USD 758.0 million in 2030 and USD 778.9 million in 2031.
In the following years, the demand for CABG procedures will persist, with the industry expected to reach USD 800.3 million in 2032 and USD 822.4 million in 2033. By 2034, the industry value will grow to USD 845.0 million, reaching USD 868.3 million in 2035. By 2036, the industry is projected to reach USD 892.2 million. The growth rate volatility index reflects a consistent but gradual increase in demand, with smaller fluctuations observed throughout the forecast period. The overall trend shows steady growth driven by the rising need for cardiovascular interventions in South Korea.
| Metric | Value |
|---|---|
| Industry Sales Value (2026) | USD 679.9 million |
| Industry Forecast Value (2036) | USD 892.2 million |
| Industry Forecast CAGR (2026 to 2036) | 2.8% |
Demand for coronary artery bypass graft (CABG) procedures in South Korea has been rising in the context of increasing cardiovascular risk factors and shifts in clinical practice patterns. Rates of coronary artery disease have grown alongside population ageing and lifestyle changes that include reduced physical activity and dietary factors associated with urban living. Patients with advanced or complex coronary lesions that cannot be managed by angioplasty or stenting are typically referred for CABG, sustaining demand for these surgical interventions. Cardiac care units in tertiary hospitals have expanded capabilities for open coronary surgery to meet this need, with an emphasis on multidisciplinary coordination among cardiologists, cardiac surgeons, and perioperative care teams. The integration of diagnostic modalities, such as coronary computed tomography angiography and functional perfusion imaging, has improved identification of candidates for bypass surgery, helping clinicians make evidence-based decisions about revascularisation strategies. South Korea’s universal health coverage under the National Health Insurance Service also supports procedural access by covering a significant portion of surgical costs, thereby reducing financial barriers that might otherwise delay or limit treatment.
Looking forward, several factors are likely to influence future demand for CABG in South Korea, presenting strategic insights for manufacturers, device suppliers, and healthcare providers. Clinical guidelines that delineate indications for surgical versus percutaneous revascularisation continue to evolve, affecting procedure volumes and device preferences. For companies in the cardiovascular device segment, opportunities may arise in supplying conduits such as saphenous vein and arterial graft materials, advanced stabilisation systems, and intraoperative imaging and monitoring technologies that improve surgical precision. Care pathways that emphasise enhanced recovery after surgery (ERAS) protocols may drive interest in technologies and consumables that reduce operative time and postoperative complications. Cardiac care providers increasingly seek devices that support long-term graft patency and patient outcomes. Engagement with clinical communities to validate product performance and align with local surgeon practices can strengthen market positioning. Predictive analytics and patient selection tools that integrate with hospital information systems may also shape how CABG procedures are planned and executed, influencing demand for complementary digital and device solutions in the South Korean healthcare environment.
The demand for coronary artery bypass graft (CABG) procedures in South Korea is segmented by technology and end user. On-pump CABG leads the technology segment, holding a 60% market share, followed by off-pump CABG and other technologies. In terms of end users, hospitals dominate the industry, accounting for 70%, with cardiology clinics, research institutes, and other healthcare providers also contributing to the demand. The growing prevalence of cardiovascular diseases and the aging population are key factors driving demand for CABG procedures.
The demand for CABG procedures in South Korea is significantly influenced by the technology used, with on-pump CABG accounting for 60% of the industry. On-pump CABG involves the use of a heart-lung machine to divert blood flow while the heart is temporarily stopped during surgery. This method is widely used due to its effectiveness in ensuring that the heart receives adequate oxygen and blood during the procedure. On-pump CABG is considered the gold standard for bypass surgeries in many cases, particularly in patients with multiple coronary blockages, as it allows surgeons to work on a still heart, offering greater precision. The larger share of on-pump CABG in South Korea is indicative of the preference for this well-established and widely available procedure, supported by advances in surgical technology and medical infrastructure. Off-pump CABG, although less common, is gaining traction due to its potential benefits, such as a lower risk of complications related to the heart-lung machine, and faster recovery times. Off-pump CABG is often preferred for patients with less severe coronary artery disease, where bypasses can be performed without halting the heart. The "others" category includes alternative approaches and emerging technologies in CABG surgery, though these methods are still relatively niche compared to on-pump and off-pump CABG.
In South Korea, hospitals are the leading end users of CABG procedures, accounting for 70% of the industry. Hospitals are the primary settings for cardiac surgeries, providing the necessary infrastructure, medical teams, and specialized equipment required for complex procedures like CABG. The majority of coronary artery bypass graft surgeries are performed in hospitals, particularly large medical centers and tertiary hospitals that offer advanced surgical care and post-operative support. Cardiology clinics, while contributing to the overall demand, play a more limited role, focusing mainly on preoperative assessments, diagnostics, and less invasive treatments. However, they may refer patients to hospitals for the actual surgery. Research institutes also contribute to the demand by driving innovations in CABG technology and surgical techniques. These institutions often focus on improving surgical outcomes and exploring new methods to reduce recovery times and complications. As cardiovascular diseases continue to rise in South Korea, particularly among the aging population, hospitals will remain the primary setting for CABG surgeries, though cardiology clinics and research institutes will play important roles in the advancement of CABG techniques and patient care. The trend toward specialized care and technological advancements suggests that demand for CABG will continue to grow, particularly in hospitals that are equipped with the latest surgical technologies.
Demand for coronary artery bypass graft (CABG) procedures in South Korea is influenced by cardiovascular disease prevalence, healthcare infrastructure capacity, and patterns in clinical practice. Coronary artery disease (CAD) remains a significant contributor to morbidity among adults, particularly in older age groups with multiple risk factors. Tertiary hospitals and specialized cardiac surgery centers serve as primary delivery points for CABG, supported by referral networks from cardiology clinics. Public and private insurance schemes shape patient access to surgical care. Procurement of graft materials, surgical instruments, and intraoperative support systems reflects both procedural volume and surgeon preference for specific technologies. Uptake of CABG is assessed against alternative revascularization options, including percutaneous coronary intervention (PCI), in clinical decision-making.
A principal driver of CABG demand is the aging demographic, which correlates with higher incidence of advanced CAD requiring surgical intervention. Epidemiological trends showing persistent rates of hypertension, hyperlipidemia, and diabetes contribute to the pool of candidates for revascularization surgery. Clinical guidelines that recommend CABG for multivessel disease and left main coronary artery involvement support surgical case volumes. Investment in cardiac surgery capacity, including advanced operating suites and post-operative intensive care units, enables providers to manage complex cases. Patient awareness of improved outcomes with timely revascularization and referrals from cardiologists also sustain demand. Domestic training programs for cardiothoracic surgeons help maintain skilled workforce availability, which is essential for procedural throughput.
Restraints include competition from minimally invasive and catheter-based revascularization alternatives, particularly drug-eluting stents used in PCI, which may be preferred for select patient profiles due to shorter recovery times. High procedural costs and extended hospital stays associated with CABG can impact patient and insurer decision-making, especially among working-age populations concerned about indirect costs. Variations in referral patterns and risk-averse clinical preferences among cardiologists may divert potential cases toward less invasive options. Geographic disparities in access to specialized cardiac surgery centers can limit uptake among patients in rural areas. Requirements for pre-operative risk stratification and optimization of comorbid conditions can extend lead times between diagnosis and surgery, affecting scheduling and resource utilization.
Emerging trends include greater integration of hybrid revascularization strategies that combine CABG with PCI within a single care pathway, aimed at optimizing clinical outcomes for complex lesions. Adoption of enhanced recovery after surgery (ERAS) protocols and minimally invasive CABG techniques is expanding, which may broaden patient eligibility and reduce length of stay. Health systems are increasingly emphasizing data-driven quality metrics, such as graft patency and long-term survival, which inform hospital rankings and influence referral patterns. Use of advanced graft materials and intraoperative imaging technologies is evolving, enabling surgeons to refine procedural precision. Collaboration between cardiac centers on outcomes research and clinical registries supports evidence-based practice and helps suppliers tailor product development to local needs.
The demand for coronary artery bypass graft (CABG) procedures in South Korea is shaped by regional healthcare infrastructure, population health trends, and the prevalence of cardiovascular diseases. South Gyeongsang, with a CAGR of 2.9%, shows a steady demand for CABG, driven by the region’s advanced medical facilities and aging population. North Jeolla, with a growth rate of 2.2%, demonstrates more moderate demand, as the region continues to enhance its healthcare services while managing a relatively smaller cardiovascular patient base. South Jeolla, with a projected CAGR of 2.6%, is seeing consistent demand, supported by its expanding healthcare sector. Jeju, with the highest projected demand growth of 3.3%, reflects increasing demand for heart surgeries driven by the region’s growing focus on health services and an aging demographic. These regional differences indicate significant opportunities for suppliers of medical devices, pharmaceuticals, and healthcare services catering to cardiovascular treatment.
| Region | CAGR (2026 to 2036) |
|---|---|
| South Gyeongsang | 2.9% |
| North Jeolla | 2.2% |
| South Jeolla | 2.6% |
| Jeju | 3.3% |
South Gyeongsang, with a projected CAGR of 2.9%, represents a steady market for suppliers of coronary artery bypass graft (CABG) medical devices and related equipment. The region has a well-established healthcare infrastructure, including several advanced medical centers that specialize in cardiovascular treatments. Manufacturers should focus on providing high-quality, durable medical devices such as grafts, surgical instruments, and heart-lung machines used in CABG surgeries. Furthermore, partnering with local hospitals and cardiovascular centers to offer training and after-sales support could enhance market penetration. As the population ages and the incidence of cardiovascular diseases increases, South Gyeongsang is expected to maintain a stable demand for CABG-related products, making it a key region for long-term growth.
North Jeolla, with a CAGR of 2.2%, is witnessing moderate demand for coronary artery bypass graft surgeries, largely due to a growing emphasis on improving regional healthcare services and access to cardiovascular treatments. While the region is less industrialized compared to South Gyeongsang, there is increasing recognition of the need for specialized cardiovascular care. Manufacturers targeting North Jeolla should focus on cost-effective, efficient CABG solutions that meet the demands of local hospitals and medical institutions, which are expanding their cardiovascular care offerings. Partnerships with local healthcare providers, coupled with awareness campaigns regarding cardiovascular health, can help raise demand for CABG procedures and related medical products in the region.
South Jeolla, with a CAGR of 2.6%, presents opportunities for CABG suppliers as the region expands its healthcare infrastructure and cardiovascular services. The growing awareness of heart disease, along with a rising elderly population, is expected to increase the demand for coronary artery bypass graft surgeries. Suppliers can seize this opportunity by offering advanced CABG products such as minimally invasive surgical tools, high-quality grafts, and comprehensive cardiovascular treatment solutions. As the region continues to develop its medical facilities and enhance its healthcare system, the demand for CABG surgeries and related medical equipment is expected to rise steadily, providing suppliers with a steady market.
Jeju, with the highest projected CAGR of 3.3%, is witnessing robust growth in the demand for coronary artery bypass graft surgeries. The region’s increasing healthcare focus, paired with an aging population, is driving this rise in demand. Jeju’s health sector is improving rapidly, with greater investment in medical infrastructure, which supports cardiovascular care, including CABG surgeries. Suppliers of medical devices and pharmaceuticals targeting Jeju should focus on providing solutions that cater to the region’s increasing number of heart disease patients. Additionally, Jeju’s growing medical tourism industry may also contribute to an influx of patients seeking CABG procedures, further driving demand. As the region continues to prioritize healthcare development, suppliers can expect long-term growth opportunities in the CABG market.
Demand for coronary artery bypass graft (CABG) procedures in South Korea is supported by the prevalence of cardiovascular disease, an ageing demographic profile, and expanding access to advanced cardiac care. Hospital cardiac surgery departments and specialized heart centers are primary buyers of CABG-related devices, including graft conduits, stabilization systems, and ancillary disposables used in operating theatres. Clinical procurement decisions emphasize product performance, documented clinical outcomes, and regulatory compliance with Korean medical device standards. Requirements in tenders and hospital contracts typically include evidence of patency rates, biocompatibility data, and ease of surgical handling. Facility investments in hybrid operating rooms and minimally invasive cardiac surgery platforms have influenced demand for CABG devices compatible with newer procedural approaches. Health insurers and government policies that support cardiovascular care have also shaped procedure volumes and equipment acquisition strategies. Surgeons and procurement committees in major South Korean hospitals priorities solutions that demonstrate reliable long-term outcomes and integration with established surgical workflows.
Competition among key suppliers of CABG devices in the South Korean market is defined by product specifications, clinical support frameworks, and documented safety and efficacy profiles. Medtronic plc is positioned as a leading supplier, with product brochures detailing graft options including arterial and venous conduits, fixation systems, and stabilization tools. Materials include specification tables for graft diameters, lengths, and biocompatibility characteristics that support clinical selection. Terumo Corp. documentation focuses on cardiovascular surgical systems and graft materials with associated handling guidelines and performance benchmarks used by surgical teams and procurement specialists. Guidant Group product literature describes cardiac surgery solutions including stabilization and imaging adjuncts, with technical data on integration with operating room systems and procedural workflows. Getinge AB brochures outline cardiovascular support technologies that complement CABG procedures, including perfusion systems and surgical instruments, with specification sheets that highlight reliability metrics and maintenance schedules relevant to hospital biomedical engineers. These brochures typically include clinical performance indicators, material properties, and procedural compatibility information that assist South Korean hospital administrators, cardiac surgeons, and procurement professionals when comparing supplier offerings against clinical and operational criteria.
| Items | Values |
|---|---|
| Quantitative Units (2026) | USD Million |
| Technology | Off-pump CABG, On-pump CABG, Others |
| Procedure | Single CABG Surgery, Double CABG Surgery, Triple CABG Surgery, Quadruple CABG Surgery, Others |
| End User | Hospitals, Cardiology Clinics, Research Institutes, Others |
| Companies | Medtronic plc, Terumo Corp., Guidant Group, Getinge AB |
| Region Covered | South Korea |
| Provinces Covered | South Gyeongsang, North Jeolla, South Jeolla, Jeju |
| Additional Attributes | Dollar sales by technology, procedure, and end user. Growth reflects rising prevalence of cardiovascular diseases, adoption of advanced grafting techniques, and greater preference for minimally invasive and off-pump CABG procedures in major hospitals and cardiac centers. |
The demand for coronary artery bypass graft in south korea is estimated to be valued at USD 679.9 million in 2026.
The market size for the coronary artery bypass graft in south korea is projected to reach USD 892.2 million by 2036.
The demand for coronary artery bypass graft in south korea is expected to grow at a 2.8% CAGR between 2026 and 2036.
The key product types in coronary artery bypass graft in south korea are on-pump cabg, off-pump cabg and others.
In terms of procedure, double cabg surgery segment is expected to command 30.0% share in the coronary artery bypass graft in south korea in 2026.
Our Research Products
The "Full Research Suite" delivers actionable market intel, deep dives on markets or technologies, so clients act faster, cut risk, and unlock growth.
The Leaderboard benchmarks and ranks top vendors, classifying them as Established Leaders, Leading Challengers, or Disruptors & Challengers.
Locates where complements amplify value and substitutes erode it, forecasting net impact by horizon
We deliver granular, decision-grade intel: market sizing, 5-year forecasts, pricing, adoption, usage, revenue, and operational KPIs—plus competitor tracking, regulation, and value chains—across 60 countries broadly.
Spot the shifts before they hit your P&L. We track inflection points, adoption curves, pricing moves, and ecosystem plays to show where demand is heading, why it is changing, and what to do next across high-growth markets and disruptive tech
Real-time reads of user behavior. We track shifting priorities, perceptions of today’s and next-gen services, and provider experience, then pace how fast tech moves from trial to adoption, blending buyer, consumer, and channel inputs with social signals (#WhySwitch, #UX).
Partner with our analyst team to build a custom report designed around your business priorities. From analysing market trends to assessing competitors or crafting bespoke datasets, we tailor insights to your needs.
Supplier Intelligence
Discovery & Profiling
Capacity & Footprint
Performance & Risk
Compliance & Governance
Commercial Readiness
Who Supplies Whom
Scorecards & Shortlists
Playbooks & Docs
Category Intelligence
Definition & Scope
Demand & Use Cases
Cost Drivers
Market Structure
Supply Chain Map
Trade & Policy
Operating Norms
Deliverables
Buyer Intelligence
Account Basics
Spend & Scope
Procurement Model
Vendor Requirements
Terms & Policies
Entry Strategy
Pain Points & Triggers
Outputs
Pricing Analysis
Benchmarks
Trends
Should-Cost
Indexation
Landed Cost
Commercial Terms
Deliverables
Brand Analysis
Positioning & Value Prop
Share & Presence
Customer Evidence
Go-to-Market
Digital & Reputation
Compliance & Trust
KPIs & Gaps
Outputs
Full Research Suite comprises of:
Market outlook & trends analysis
Interviews & case studies
Strategic recommendations
Vendor profiles & capabilities analysis
5-year forecasts
8 regions and 60+ country-level data splits
Market segment data splits
12 months of continuous data updates
DELIVERED AS:
PDF EXCEL ONLINE
Coronary Artery Bypass Grafts Market Size and Share Forecast Outlook 2025 to 2035
Demand for Coronary Artery Bypass Graft in United Kingdom Size and Share Forecast Outlook 2026 to 2036
Demand for Coronary Artery Bypass Graft in Japan Size and Share Forecast Outlook 2025 to 2035
Demand for Coronary Artery Bypass Graft in USA Size and Share Forecast Outlook 2025 to 2035
Demand for Aortic Endograft in South Korea Size and Share Forecast Outlook 2026 to 2036
Demand for Respiratory Inhaler Devices in South Korea Size and Share Forecast Outlook 2026 to 2036
South Korea Intellectual Property Market Size and Share Forecast Outlook 2025 to 2035
South Korea Sports Tourism Market Size and Share Forecast Outlook 2025 to 2035
South Korea Tourism Market Trends - Growth, Demand & Analysis 2025 to 2035
South Korea Power Tools Market Report – Trends, Demand & Growth 2025-2035
South Korea Mobile Sterile Units Market Report – Growth, Demand & Forecast 2025-2035
South Korea Hyaluronic Acid Products Market Growth – Trends, Demand & Innovations 2025-2035
South Korea DNA Polymerase Market Growth – Innovations, Trends & Forecast 2025-2035
South Korea 3D Bioprinted Human Tissue Market Trends – Demand & Forecast 2025-2035
Demand for Whiskey in South Korea Size and Share Forecast Outlook 2026 to 2036
Demand for Calcite in South Korea Size and Share Forecast Outlook 2026 to 2036
Kombucha Demand in South Korea Size and Share Forecast Outlook 2026 to 2036
Demand for Insurtech in South Korea Size and Share Forecast Outlook 2026 to 2036
Demand for Gemstones in South Korea Size and Share Forecast Outlook 2026 to 2036
Demand for Pea Grits in South Korea Size and Share Forecast Outlook 2026 to 2036
Demand for Coronary Artery Bypass Graft in South Korea
Thank you!
You will receive an email from our Business Development Manager. Please be sure to check your SPAM/JUNK folder too.
